Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07220863 · ClinicalTrials.gov registry record
Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai
A clinical trial of Breast Cancer Awareness, sponsored by Feminai.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT07220863 is a study of Breast Cancer Awareness that is actively recruiting participants, run by Feminai. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07220863, a study of Breast Cancer Awareness, is actively recruiting participants, sponsored by Feminai.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with mammography and, when available, biopsy to assess sensitivity and negative predictive value. Feminai is investigational, intended to support clinical decision-making, and does not replace standard diagnostic tests.
Conditions Studied
Study Locations (1)
Texas
- Solis Mammography Frisco at Stonebriar - Frisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-10-05 |
| Est. Completion | 2026-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07220863
The ClinicalTrials.gov registry entry for NCT07220863 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Feminai, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer Awareness appearing as the primary indexed condition, and to 0 interventions.
NCT07220863 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT07220863 about?
NCT07220863 is a clinical study titled "Breast Mapping and Detection of Suspicious Breast Lesions Using Feminai". Prospective observational study evaluating the safety and accuracy of Feminai 1.0, an at-home adhesive patch that measures skin temperature and electrical impedance to map each breast. Up to 300 women (ages 25-75) undergoing screening will have one study visit; Feminai results will be compared with ...
What is the current status of trial NCT07220863?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-10-05. Estimated completion is 2026-09-05.
What conditions does trial NCT07220863 study?
This clinical trial studies the following conditions: Breast Cancer Awareness.
Who is sponsoring clinical trial NCT07220863?
This trial is sponsored by Feminai, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07220863 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer Awareness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.